You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 23, 2024

List of Excipients in API quizartinib

✉ Email this page to a colleague

« Back to Dashboard

Excipients in NDA-approved (novel) drugs containing quizartinib

Subscribe to access the full database, or Subscribe
Company	Tradename	Ingredient	NDC	Excipient	Potential Generic Entry
Daiichi Sankyo Inc	VANFLYTA	quizartinib	65597-504	CELLULOSE, MICROCRYSTALLINE	2030-07-20
Daiichi Sankyo Inc	VANFLYTA	quizartinib	65597-504	HYDROXYPROPYL BETADEX	2030-07-20
Daiichi Sankyo Inc	VANFLYTA	quizartinib	65597-504	HYPROMELLOSE	2030-07-20
Daiichi Sankyo Inc	VANFLYTA	quizartinib	65597-504	MAGNESIUM STEARATE	2030-07-20
Daiichi Sankyo Inc	VANFLYTA	quizartinib	65597-504	TALC	2030-07-20
Daiichi Sankyo Inc	VANFLYTA	quizartinib	65597-504	TITANIUM DIOXIDE	2030-07-20
Daiichi Sankyo Inc	VANFLYTA	quizartinib	65597-504	TRIACETIN	2030-07-20
>Company	>Tradename	>Ingredient	>NDC	>Excipient	>Potential Generic Entry

Detailed excipient profiles for quizartinib

Excipient focus: CELLULOSE, MICROCRYSTALLINE

quizartinib drug variants containing CELLULOSE, MICROCRYSTALLINE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Daiichi Sankyo Inc	quizartinib	65597-504
>Company	>Ingredient	>NDC

quizartinib drug variants not containing CELLULOSE, MICROCRYSTALLINE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: HYDROXYPROPYL BETADEX

quizartinib drug variants containing HYDROXYPROPYL BETADEX

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Daiichi Sankyo Inc	quizartinib	65597-504
>Company	>Ingredient	>NDC

quizartinib drug variants not containing HYDROXYPROPYL BETADEX

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: HYPROMELLOSE

quizartinib drug variants containing HYPROMELLOSE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Daiichi Sankyo Inc	quizartinib	65597-504
>Company	>Ingredient	>NDC

quizartinib drug variants not containing HYPROMELLOSE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: MAGNESIUM STEARATE

quizartinib drug variants containing MAGNESIUM STEARATE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Daiichi Sankyo Inc	quizartinib	65597-504
>Company	>Ingredient	>NDC

quizartinib drug variants not containing MAGNESIUM STEARATE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: TALC

quizartinib drug variants containing TALC

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Daiichi Sankyo Inc	quizartinib	65597-504
>Company	>Ingredient	>NDC

quizartinib drug variants not containing TALC

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: TITANIUM DIOXIDE

quizartinib drug variants containing TITANIUM DIOXIDE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Daiichi Sankyo Inc	quizartinib	65597-504
>Company	>Ingredient	>NDC

quizartinib drug variants not containing TITANIUM DIOXIDE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: TRIACETIN

quizartinib drug variants containing TRIACETIN

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Daiichi Sankyo Inc	quizartinib	65597-504
>Company	>Ingredient	>NDC

quizartinib drug variants not containing TRIACETIN

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.